
zzso zzso zzso was the first zzso zzso insulin analogue to be licensed for use in the treatment of diabetes zzso 

This review considers the use of insulin zzso in the treatment of type 2 diabetes zzso 

zzso Cochrane and zzso databases were searched for relevant papers from the year 2000 zzso 

zzso zzso provides at least equivalent zzso control and is associated with less zzso especially nocturnal zzso zzso to its 24 h zzso profile, which allows more aggressive zzso to achieve zzso zzso zzso has been shown to be safely initiated both individually and within a group setting and zzso zzso zzso by patients are effective in achieving diabetes zzso Despite these advantages, caution is needed as clinical guidelines do not advocate its use in all people with zzso until clinical efficacy and cost effectiveness have been zzso However, insulin zzso is a welcome addition to the plethora of treatment options available for zzso 

